Oncology News

Survival and recurrence rates were unaffected by HIV infection among patients who underwent liver transplantation for hepatocellular carcinoma, according to a poster presentation at CROI 2015.

The use of statins decreased the risk for primary liver cancer, especially in patients with liver disease and diabetes, according to newly published data.

Nexavar and transarterial chemoembolization combination therapy for advanced hepatocellular carcinoma was well tolerated by elderly patients, according to study data.

Updated results from the HEAT Study indicated an increased overall survival rate among patients with primary liver cancer when treated with ThermoDox combined with radiofrequency ablation, according to a press release.

Liver transplant recipients were at increased risk for hepatocellular carcinoma recurrence if they received a liver from a donor aged at least 60 years or from a nonlocal share distribution, according to study data.

In a retrospective cohort study, incidence of hepatocellular carcinoma occurred over time among adults with chronic hepatitis B virus infection being treated with entecavir or tenofovir, according to study data.

Radiotherapy was effective in palliation for treating spinal metastases from hepatocellular carcinoma, according to study data from a retrospective analysis.

World Cancer Day is today, February 4. Healio.com/Hepatology compiled a list of the latest studies focusing on hepatocellular carcinoma research and advancements. 

When combined with tissue sampling, using probe-based confocal laser endomicroscopy during endoscopic retrograde cholangio-pancreatography diagnosed cholangiocarcinoma with greater accuracy and sensitivity compared with standard procedures, according to new research data.

Mipsagargin was effective in stabilizing hepatocellular carcinoma progression and was well tolerated among a cohort of patients with hepatocellular carcinoma, according to results of a phase 2 clinical trial presented at the Gastrointestinal Cancers Symposium.